BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu ZH, Gu XJ, Shi KZ, Li X, Chen DD, Chen L. Association between genetic polymorphisms of inflammatory response genes and the risk of ovarian cancer. J Formos Med Assoc 2016;115:31-7. [PMID: 25659662 DOI: 10.1016/j.jfma.2015.01.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Luo YQ, Wang D, Gong T, Zhu J. An updated meta-analysis of 37 case-control studies on the association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer susceptibility. Oncotarget 2016;7:58659-70. [PMID: 27463002 DOI: 10.18632/oncotarget.10808] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhang M, Huang J, Tan X, Bai J, Wang H, Ge Y, Xiong H, Shi J, Lu W, Lv Z, Liang C. Common Polymorphisms in the NFKBIA Gene and Cancer Susceptibility: A Meta-Analysis. Med Sci Monit 2015;21:3186-96. [PMID: 26488500 DOI: 10.12659/msm.895257] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
3 Fu W, Zhuo ZJ, Chen YC, Zhu J, Zhao Z, Jia W, Hu JH, Fu K, Zhu SB, He J. NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies. Oncotarget. 2017;8:9806-9822. [PMID: 28039461 DOI: 10.18632/oncotarget.14190] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
4 Amador MA, Cavalcante GC, Santos NP, Gusmão L, Guerreiro JF, Ribeiro-dos-Santos Â, Santos S. Distribution of allelic and genotypic frequencies of IL1A, IL4, NFKB1 and PAR1 variants in Native American, African, European and Brazilian populations. BMC Res Notes 2016;9:101. [PMID: 26879815 DOI: 10.1186/s13104-016-1906-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
5 Plantinga TS, Petrulea MS, Oosting M, Joosten LAB, Piciu D, Smit JW, Netea-maier RT, Georgescu CE. Association of NF-κB polymorphisms with clinical outcome of non-medullary thyroid carcinoma. Endocrine-Related Cancer 2017. [DOI: 10.1530/erc-17-0033] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ahmed AB, Zidi S, Almawi W, Ghazouani E, Mezlini A, Loueslati BY, Stayoussef M. Single nucleotide polymorphism of transforming growth factor-β1 and interleukin-6 as risk factors for ovarian cancer. Cent Eur J Immunol 2020;45:267-75. [PMID: 33437178 DOI: 10.5114/ceji.2020.101242] [Reference Citation Analysis]
7 Wang D, Xie T, Xu J, Wang H, Zeng W, Rao S, Zhou K, Pei F, Zhou Z. Genetic association between NFKB1 -94 ins/del ATTG Promoter Polymorphism and cancer risk: a meta-analysis of 42 case-control studies. Sci Rep 2016;6:30220. [PMID: 27443693 DOI: 10.1038/srep30220] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
8 Dhaini HR, Daher Z. Genetic polymorphisms of PPAR genes and human cancers: evidence for gene-environment interactions. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2019;37:146-79. [PMID: 31045458 DOI: 10.1080/10590501.2019.1593011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]